( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
8510.61
7747.79
6031.86
4765.8
Total Expenditure
6922.61
6168.39
4856.44
3502.46
PBIDT (Excl OI)
1588
1579.4
1175.42
1263.34
Other Income
51.21
44.28
48.3
48.56
Operating Profit
1639.21
1623.68
1223.71
1311.9
Interest
34.22
36.2
35.62
43.78
Exceptional Items
NA
NA
NA
-40.19
PBDT
1604.99
1587.48
1188.09
1227.93
Depreciation
21.13
21.84
22.35
16.27
Profit Before Tax
1583.86
1565.64
1165.74
1211.66
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
1201.95
1163.45
863.89
937.66
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
1201.95
1163.45
863.89
937.66
Minority Interest
0.24
-0.49
0.55
0.48
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
1202.18
1162.96
864.44
938.14
Equity Capital
208.69
208.49
208.49
208.49
Calculated EPS
11.52
11.15
8.29
8.99
Calculated EPS (Annualised)
46.08
44.62
33.16
35.99
No of Public Share Holdings
26795547
26696324
26696324
26696324
% of Public Share Holdings
25.68
25.61
25.61
25.61
PBIDTM% (Excl OI)
18.65
20.38
19.48
26.50
PBIDTM%
19.26
20.95
20.28
27.52
PBDTM%
18.85
20.48
19.69
25.76
PBTM%
18.61
20.20
19.32
25.42
PATM%
14.12
15.01
14.32
19.67